| __timestamp | PTC Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 13774000 |
| Thursday, January 1, 2015 | 82080000 | 22479000 |
| Friday, January 1, 2016 | 97130000 | 27388000 |
| Sunday, January 1, 2017 | 121271000 | 35610000 |
| Monday, January 1, 2018 | 153548000 | 49007000 |
| Tuesday, January 1, 2019 | 202541000 | 61139000 |
| Wednesday, January 1, 2020 | 245164000 | 68836000 |
| Friday, January 1, 2021 | 285773000 | 97592000 |
| Saturday, January 1, 2022 | 325998000 | 106903000 |
| Sunday, January 1, 2023 | 332540000 | 120998000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial for success. Over the past decade, PTC Therapeutics, Inc. and Vericel Corporation have demonstrated contrasting strategies in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, PTC Therapeutics saw a staggering 642% increase in SG&A expenses, peaking at $332 million in 2023. In contrast, Vericel Corporation's expenses grew by 779%, reaching $121 million in the same year. This divergence highlights PTC's aggressive expansion strategy, while Vericel's more conservative approach reflects a focus on sustainable growth. As these companies navigate the evolving biotech landscape, their SG&A efficiency will be pivotal in determining their long-term viability and market position.
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
Neurocrine Biosciences, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Insmed Incorporated vs PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Vericel Corporation
Alkermes plc or PTC Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Vericel Corporation
Comparing SG&A Expenses: Vericel Corporation vs Merus N.V. Trends and Insights
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.